Company news
TSO3 Inc news in 2018
TSO3 Inc's news releases, calls and decks from 2018, newest first.
American Journal of Infection Control publishes TSO3 study on terminal sterilization of duodenoscopes
November 15, 2018
TSO3 Reports Third Quarter 2018 Results
November 6, 2018
TSO3 Awarded Low Temperature Sterilization Contract pursuant to a Quebec Tender
October 30, 2018
TSO3 Named Winner of South Carolina Innovation Award
October 29, 2018
TSO3 to Report Third Quarter 2018 Results on Wednesday, November 7, 2018
October 25, 2018
TSO3 Provides a Commercialization Update
October 4, 2018
TSO3 Appoints Martin J. Madden to the Board of Directors
August 29, 2018
UCHealth performs first patient procedure in Colorado using STERIZONE® technology
August 20, 2018
TSO3 Reports Second Quarter 2018 Results
August 7, 2018
TSO3 Announces Closing of US$20 million Financing with Courage Capital to Commercialize the STERIZONE® VP4 Sterilizer and Support Getinge Transition
August 1, 2018
TSO3 to Report Second Quarter 2018 Results on Wednesday, August 8, 2018
July 30, 2018
Altru® Health System Improves Patient Care with Expanded Use of Cutting-Edge Sterilization Technology
June 14, 2018
TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders and the Appointment New Chairperson
May 10, 2018
TSO3 Obtains New Clearance for the STERIZONE® VP4 Sterilizer
May 9, 2018
TSO3 Reports First Quarter 2018 Results
May 8, 2018
TSO3 to Report First Quarter 2018 Results and Hold Annual Meeting of Shareholders on Wednesday, May 9, 2018
April 30, 2018
TSO3 's Chief Science Officer to moderate Educational Panel at the IAHCSMM Annual Congress
April 26, 2018
TSO3 Details Results of Prion Inactivation Studies
April 26, 2018
TSO3 Appoints Dr. Douglas Dieter to its Board of Directors
April 2, 2018
TSO3 Reports Fourth Quarter and Full Year 2017 Results
March 20, 2018
TSO3 Submits Response to US Regulators in Support of Terminal Sterilization of Duodenoscopes
March 19, 2018
TSO3's STERIZONE® VP4 Sterilizer Receives 510(k) Clearance for a Significant Enhancement
March 14, 2018
TSO3 Sets Fourth Quarter and Full Year 2017 Earnings Call for Wednesday, March 21, 2018 at 8: 30 a.m. EDT
March 7, 2018
TSO3 to Present at the RBC Capital Markets Healthcare Conference
February 14, 2018
TSO3 and Global Distributor Agree on Co-Commercial Strategy for North America
January 25, 2018
TSO3 Provides an Operational Update
January 25, 2018
Decks in 2018
- Investor Presentation (November 2018)
Investor deck · 20 slides · November 2018
- Investor Presentation (November 2018)
Investor deck · 20 slides · November 2018
- Investor Presentation (May 2018)
Investor deck · 18 slides · May 2018
- Investor Presentation (May 2018)
Investor deck · 18 slides · May 2018
- Investor Presentation (February 2018)
Investor deck · 22 slides · Feb 22, 2018